Cambridge Investment Research Advisors’s Nutanix NTNX Stock Holding History
Bought
Maintained
Sold
Other funds holding NTNX
SIMG
OAM
PCM
HIIFS
Cambridge Investment Research Advisors's NTNX Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its Nutanix (NTNX) stake by 46% in Q2 2026, buying an estimated $191K and bringing the position to 13,489 shares worth $687K. The position accounts for ﹤0.01% of the portfolio, ranked #2658.
Cambridge Investment Research Advisors first reported a position in NTNX in Q4 2017 and has held it in 19 quarters since. The position peaked at $771K in Q3 2025. 185 funds tracked by Wall St. Rank hold NTNX as of Q2 2026.
- Cambridge Investment Research Advisors held 13,489 shares of Nutanix worth $687K as of Q2 2026.
- Cambridge Investment Research Advisors bought 4,224 Nutanix shares in Q2 2026, an estimated $191K.
- Nutanix made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2658 holding.
- Cambridge Investment Research Advisors first reported a position in Nutanix in Q4 2017 and has held it in 19 quarters since.
- Cambridge Investment Research Advisors's Nutanix position peaked at $771K in Q3 2025.
- 185 funds tracked by Wall St. Rank held Nutanix as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.